These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 970783)

  • 21. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates.
    Chistolini A; Mazzucconi MG; Tirindelli MC; La Verde G; Ferrari A; Mandelli F
    Acta Haematol; 1990; 83(3):163-5. PubMed ID: 2109459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin on chronically induced intravascular coagulation in dogs.
    Owen CA; Bowie EJ
    Am J Physiol; 1975 Aug; 229(2):449-54. PubMed ID: 1163671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin-III transfusion in disseminated intravascular coagulation.
    Schipper HG; Jenkins CS; Kahlé LH; ten Cate JW
    Lancet; 1978 Apr; 1(8069):854-6. PubMed ID: 76800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor Xa and prothrombin: mechanism of action of FEIBA.
    Turecek PL; Varadi K; Gritsch H; Auer W; Pichler L; Eder G; Schwarz HP
    Vox Sang; 1999; 77 Suppl 1():72-9. PubMed ID: 10529694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravascular coagulation in acute poisoning].
    Bakuła S
    Pol Tyg Lek; 1982 Nov; 37(41-42):1251-3. PubMed ID: 7163075
    [No Abstract]   [Full Text] [Related]  

  • 28. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
    Dickneite G
    Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated intravascular coagulation due to intravenous administration of hetastarch.
    Chang JC; Gross HM; Jang NS
    Am J Med Sci; 1990 Nov; 300(5):301-3. PubMed ID: 1700605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant factor VIIa does not induce hypercoagulability in vitro.
    Gallistl S; Cvirn G; Muntean W
    Thromb Haemost; 1999 Feb; 81(2):245-9. PubMed ID: 10064000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic concentrates from blood donor components and hemostasis].
    Gavrilov OK
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):3-7. PubMed ID: 424400
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
    McLaughlin LF; Drummond O; MacGregor IR
    Thromb Haemost; 1992 Nov; 68(5):511-5. PubMed ID: 1455396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
    Rasche H; Bindewald H; Köhle W; Scheck R; Heinrich R; Seibert K
    Dtsch Med Wochenschr; 1977 Mar; 102(9):319-23. PubMed ID: 300053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.
    Lusher JM
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):49-52. PubMed ID: 7939776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of characteristics in the development of different toxigenic syndromes of disseminated intravascular blood coagulation].
    Barkagan ZS; Glazunova GA; Taranina TS
    Patol Fiziol Eksp Ter; 1988; (2):67-70. PubMed ID: 3412813
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Prothrombin-complex concentrates in liver disease.
    Lancet; 1975 Aug; 2(7929):328. PubMed ID: 50541
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy.
    Key NS; Christie B; Henderson N; Nelsestuen GL
    Thromb Haemost; 2002 Jul; 88(1):60-5. PubMed ID: 12152680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of inhibitors to factor VIII.
    Kasper CK
    Prog Hematol; 1981; 12():143-63. PubMed ID: 6803298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.